medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2016, Number 09

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (09)

Prevalence of HPV high-risk serotypes detected by PCR in patients with normal cervical cytology at the Hospital Regional Adolfo López Mateos, ISSSTE

Martínez-Portilla RJ, López-Velázquez JL, Martínez-Rojas GC, Aguilar-Villagómez MI, de la Torre-Rendón FE, Villafán-Bernal JR

Language: Spanish
References: 20
Page: 556-561
PDF size: 294.98 Kb.


ABSTRACT

Background: Is fundamental to determine the prevalence of human papiloma virus (HVP) high-risk serotypes in local and regional population in order for health providers to offer patients, vaccines and treatments against specific population-based serotypes.
Objetive: To determine the prevalence of HPV High risk serotypes detected by PCR in patients with normal cytology from the ISSSTE Adolfo Lopez Mateos Regional Hospital.
Methods: An observational, descriptive, prospective study was conducted from cervical cytologies and high risk HPV test by PCR in patients from the Regional Hospital Adolfo López Mateos, ISSSTE, during the period January 2013-December 2015. Cases of patients with negative cervical cytology were included. Information about age, the result of cervical cytology and high risk HPV test by PCR was obtained. The overall prevalence of HPV infection and the most prevalent serotypes by age groups were calculated.
Results: A total of 3258 cervical smears were performed, of which 2557 were negative (78.4%), from this, the global prevalence of HPV infection was 10.2% (n=262). We found that 1.8% (n = 45) of negative reports had HPV16 infection, 0.5% (n=13) had HPV18 and 8.9% (n = 227) were infected by Viral Pool of other high-risk serotypes. The prevalence of infection by viral pool of high risk serotypes was 11.5% in women ‹20 years, 12.9% in women between 20-29 years and 22.2% in women between 30-39 years. This prevalence was lower in patients older than 40 years (p‹0.05).
Conclusions: A higher prevalence of viral pool high risk serotypes was found in patients with normal cytology, than the HPV16 and HPV-8 prevalence, which was significantly higher in women younger than 40 years.


REFERENCES

  1. Muñoz N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case control study in Colombia and Spain. Int J Cancer. 1992;52:743-9.

  2. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Déry M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415-23.

  3. Rubin MA, Kleter B, Zhou M, 2001: Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am. J. Pathol. 159 (4) 1211–8

  4. Daling JR, Madeleine MM, Schwartz SM, 2002: A population– based study of squamous cell vaginal cancer; HPV and cofactors. Gynecol.oncol. 84(2): 263–70

  5. Trimble CL, Hildesheim A, Brinton LA, 1996: Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol. 87 (1): 59- 64

  6. World Health Statistics 2015. Geneva, World Health Organization, 2013. Available at: http://www.who.int/gho/ publications/world_health_statistics/2015/en/ [Accessed April 2016]

  7. Parkin DM, Whelan SL, Ferlay J. Cancer incidence in five continents, vol VII. International Agency for Research on Cancer. Scientific Publications No. 143. Lyon; IARC, 1997.

  8. INEGI. Página del Instituto Nacional de Estadística y Geografía “Sistema de cuentas nacionales 2013”. Recuperado el 8 de Abril del 2016, de http://www3.inegi.org.mx/sistemas/ mexicocifras/default.aspx]

  9. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC

  10. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010; 202(12):1789-99.

  11. Lazcano-Ponce E, Lörincz A, Salmerón J, Fernández I, Cruz A, Hernández P, Mejia I, Hernández-Ávila M: A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Cancer Causes Control. 2010; 21(10): 1693-1700.

  12. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, Brotons M, Mena M, Cosano R, Muñoz J, Bosch FX, de Sanjosé S, Castellsagué X. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in [Continent]. Summary Report 2015-12-23. Recuperado en Abril de 2016 de: http://www.hpvcentre.net/summaryreport.php

  13. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Muñoz N, Bosch X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNS in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7:453-59.

  14. Shambayati B. Cytopathology. Oxford University Press. London: 2011. pp.145-150.

  15. Alameda F, Fusté P, Albert S, Romero E, Gimferrer E, Soler I, Conangla M, Carreras R, Serrano S. Citología en medio líquido (Thin Prep Pap Test). Un año de experiencia. Prog Obstet Ginecol. 2007; 50(4): 73173-4.

  16. Roche. Cobas® HPV Test. Roche. 2016. Obtenido de: http:// molecular.roche.com/assays/ Pages/cobasHPVTest.aspx

  17. Salcedo M, Pina-Sanchez, Vallejo Ruiz V, et al. Human papillomavirus genotypes among females in Mexico: a study from the Mexican Institute for Social Security. Asian Pac J Cancer Prev. 2014;15(23):10061-6.

  18. Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés-Gutiérrez EI, Salgado-Bernabé ME, Ramos-González NP, Ortega-Cervantes L, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015; 87(5):871-84.

  19. Almonte M, Murillo R, Sánchez GI, Jerónimo J, Salmerón J, Ferreccio C, Lazcano-Ponce E, Herrero R. Nuevos paradigmas y desafíos en la prevención y control del cáncer de cuello uterino en América Latina. Salud Publica Mex 2010;52:544-559.

  20. Illades-Aguiar B, Alarcón-Romero Ldel C, Antonio-Véjar V, Zamudio-López N, Sales-Linares N, Flores-Alfaro E, Fernández-Tilapa G, Vences-Velázquez A, Muñoz-Valle JF, Leyva-Vázquez MA. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol. 2010; 117(2):291-6.




2020     |     www.medigraphic.com